Abstracts

Filters

Clear Filters
All Days Sun, Sep 27 Mon, Sep 28 Tue, Sep 29 Wed, Sep 30

Sunday, September 27

5:20 PM - 5:25 PM ET

1087 - Fast Forward: Hypofractionated, Dose De-escalated Radiotherapy for Multiple Myeloma
Speaker: Deshane, Alok, MD - MSKCC, New York, NY
5:20 PM - 5:30 PM ET

134 - Safety and Efficacy of Stereotactic Body Radiotherapy (SBRT) for Localized Renal Pelvic and Ureteral Carcinoma
Speaker: Li, Xiaoying, MD - Peking University First Hospital, Beijing, Beijing
5:20 PM - 5:30 PM ET

140 - Endocrine Therapy Adherence after RT Omission in Estrogen Receptor-Positive Early-Stage Breast Cancer
Speaker: Jiang, Shannon, MD - Washington University/B-JH/SLCH Consortium, St. Louis, MO
5:20 PM - 5:30 PM ET

145 - Federated Deep Ensemble Learning for MRI-Based Brain Metastasis Segmentation: An International Multi-Center Development
Speaker: Zhao, Jingtong, PhD - Duke University, Durham, NC
5:25 PM - 5:30 PM ET

1020 - Prospective Study of Surface Guided Radiation Therapy (SGRT) Alone or in Combination with Fiducials for Free Breathing (FB) vs. Breath Hold (BH) Stereotactic Body Radiation Therapy (SBRT) Treatments of the Lung
Speaker: Heinzerling, John, MD - Atrium Health Levine Cancer, Wake Forest School of Medicine, Southeast Radiation Oncology Group PA, Charlotte, NC
5:25 PM - 5:30 PM ET

1088 - Prognostic Significance of Baseline Metabolic Tumor Volume in Relapsed/Refractory Aggressive B-cell Lymphoma Patients Treated with Bispecific Antibodies: A Multi-Institution Discovery-Validation Study
Speaker: Johnson, Bryan, MD, MBA - Mayo Clinic Florida, Jacksonville, FL
5:30 PM - 5:35 PM ET

1021 - Adebrelimab as Maintenance Therapy Following Hyperfractionated Simultaneous Integrated Boost Radiotherapy Plus Chemotherapy in Limited-Stage Small-Cell Lung Cancer: A Prospective, Multicenter, Single-Arm Phase II Trial
Speaker: Yu, Jiayi, MD, PhD - Peking University Cancer Hospital and Institute, Beijing, Beijing
5:30 PM - 5:35 PM ET

1089 - Radiation Therapy for Bridging to CD19 CAR T-Cell Therapy for Large B-Cell Lymphoma - A Multicenter Analysis by the GoCART Coalition and the EBMT Lymphoma Working Party
Speaker: Oertel, Michael, MD, PhD - University Hospital of Muenster, Muenster, Nordrhein-
5:30 PM - 5:40 PM ET

135 - Evaluation of 68Ga-NYM 096 CAIX PET/CT for Systemic Therapy-Radiotherapy Integration and Target Definition in Metastatic ccRCC (NYCRRT)
Speaker: Ma, Mingwei, MD - Peking University First Hospital, Beijing, Beijing
5:30 PM - 5:40 PM ET

141 - Overall Survival in Oncology Phase III Trials: An Individual Patient Level Meta-Analysis (OPTIMA)
Speaker: Sherry, Alexander, MD - Mayo Clinic Rochester, Rochester, MN
5:30 PM - 5:40 PM ET

146 - Cross-Institutional Validation of a Mixed-Cohort-Trained 3D Res-U-Net for Cervical-Bed CTV Segmentation in Cervical Cancer Radiotherapy
Speaker: Lai, Chia Yu, MS - National Yang Ming Chiao Tung University, Tinan City, Tainan
5:35 PM - 5:40 PM ET

1022 - Optimizing Nodal Target Delineation in Limited-Stage Small Cell Lung Cancer: A Large-Scale, Multi-Institutional Study
Speaker: Wang, Xiaolong, MS - Shandong Cancer Hospital and Institute, jinan, Shandong